Pharmacokinetics of cefepime administered by i.v. and i.m. routes to ewes

被引:19
作者
Ismail, M [1 ]
机构
[1] Cairo Univ, Fac Vet Med, Dept Pharmacol, Giza 12211, Egypt
关键词
D O I
10.1111/j.1365-2885.2005.00689.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of cefepime were studied following i.v. and i.m. administration of 20 mg/kg in 10 ewes. Following i.v. administration of a single dose, the plasma concentration-time curves of cefepime were best fitted using a two-compartment open model. The elimination half-life (t(1/2 beta)) was 1.76 +/- 0.07 h, volume of distribution at steady-state [V-d(ss)] was 0.32 +/- 0.01 L/kg and total body clearance (Cl-B) was 2.37 +/- 0.05 mL/min.kg. Following i.m. administration, the drug was rapidly absorbed with an absorption half-life (t(1/2ab)) of 0.49 +/- 0.05 h, maximum plasma concentration (C-max) of 31.9 +/- 1.5 mu g/mL was attained at (t(max)) 1.1 +/- 0.2 h and the drug was eliminated with an elimination half-life (t(1/2el)) of 2.06 +/- 0.11 h. The systemic bioavailability (F) after i.m. administration of cefepime was 86.8 +/- 7.5%. The extent of plasma protein binding measured in vitro was 14.8 +/- 0.54%. The drug was detected in urine for 36 h postadministration by both routes.
引用
收藏
页码:499 / 503
页数:5
相关论文
共 27 条
[11]  
HAMELIN BA, 1993, PHARMACOTHERAPY, V13, P465
[12]   Disposition kinetics, Bioavailability and renal clearance of cefepime in calves [J].
Ismail, MM .
VETERINARY RESEARCH COMMUNICATIONS, 2005, 29 (01) :69-79
[13]   PHARMACOKINETIC DISPOSITION AND BACTERICIDAL ACTIVITIES OF CEFEPIME, CEFTAZIDIME, AND CEFOPERAZONE IN SERUM AND BLISTER FLUID [J].
KALMAN, D ;
BARRIERE, SL ;
JOHNSON, BL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (02) :453-457
[14]   COMPARISON OF A NEW CEPHALOSPORIN, BMY 28142, WITH OTHER BROAD-SPECTRUM BETA-LACTAM ANTIBIOTICS [J].
KESSLER, RE ;
BIES, M ;
BUCK, RE ;
CHISHOLM, DR ;
PURSIANO, TA ;
TSAI, YH ;
MISIEK, M ;
PRICE, KE ;
LEITNER, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (02) :207-216
[15]   PHARMACOKINETICS OF CEFEPIME IN PATIENTS WITH THE SEPSIS SYNDROME [J].
KIEFT, H ;
HOEPELMAN, AIM ;
KNUPP, CA ;
VANDIJK, A ;
BRANGER, JM ;
STRUYVENBERG, A ;
VERHOEF, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 :117-122
[16]   PHARMACOKINETICS OF CEFEPIME IN PATIENTS WITH RESPIRATORY-TRACT INFECTIONS [J].
KOVARIK, JM ;
TERMAATEN, JC ;
RADEMAKER, CMA ;
DEENSTRA, M ;
HOEPELMAN, IM ;
HART, HC ;
MATZKE, GR ;
VERHOEF, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (10) :1885-1888
[17]  
NAKANOMYO H, 1992, JAPANEASE J ANTIBIOT, V24, P938
[18]  
NEU HC, 1985, AM J MED, V79, P2
[19]  
OSBALDISTON G. W., 1971, CLIN BIOCH DOMESTIC, P24
[20]  
PECHERE JC, 1995, J ANTIMICROB CHEMOTH, V20, P383